Juva Life, Inc. (TSE:JUVA) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Juva Life Inc., a life science company specializing in pharmaceutical research and cannabis production, has announced a delay in filing their annual financial statements for 2023 due to auditing complexities stemming from a recent reorganization. The company has received a management cease trade order against its CEO and CFO until the filings are completed, which is expected by June 28, 2024. In the interim, Juva Life will provide bi-weekly updates in compliance with regulatory guidelines.
For further insights into TSE:JUVA stock, check out TipRanks’ Stock Analysis page.